Page 4 - Joshuat Brumm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joshuat brumm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joshuat Brumm Today - Breaking & Trending Today

Dyne Therapeutics (NYSE:DYN) Trading Down 8.1%

Shares of Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) traded down 8.1% during mid-day trading on Tuesday . The company traded as low as $10.57 and last traded at $10.62. 176,104 shares were traded during mid-day trading, a decline of 58% from the average session volume of 419,320 shares. The stock had previously closed […] ....

United States , Richard William Scalzo , Joshuat Brumm , Securities Exchange Commission , Dyne Therapeutics Inc , Dyne Therapeutics Company Profile , Mirae Asset Global Investments Co , International Biotechnology Trust , Dyne Therapeutics , Get Free Report , Exchange Commission , Biotechnology Trust , Mirae Asset Global Investments , Asset Global Investments , Dyne Therapeutics Daily , Nyse Dyn ,

Dyne Therapeutics (NYSE:DYN) Downgraded to Sell at StockNews.com

StockNews.com lowered shares of Dyne Therapeutics (NYSE:DYN – Free Report) from a hold rating to a sell rating in a research report sent to investors on Sunday morning. Dyne Therapeutics Stock Up 1.6 % DYN stock opened at $11.23 on Friday. The company has a market capitalization of $654.82 million, a price-to-earnings ratio of -3.37 […] ....

United States , Joshuat Brumm , Group Plc , Allspring Global Investments Holdings , Sphera Funds Management , Dyne Therapeutics Inc , Tower Research Capital , Dyne Therapeutics Company Profile , Dyne Therapeutics , Free Report , Get Free Report , Global Investments Holdings , Funds Management , General Group Plc , Research Capital , Dyne Therapeutics Daily , Nyse Dyn , Stocknews Com ,

Dyne Therapeutics (NYSE:DYN) Downgraded by StockNews.com

StockNews.com downgraded shares of Dyne Therapeutics (NYSE:DYN – Free Report) from a hold rating to a sell rating in a report published on Sunday. Dyne Therapeutics Price Performance DYN stock opened at $11.05 on Friday. Dyne Therapeutics has a 52-week low of $8.04 and a 52-week high of $15.63. The company’s 50 day simple moving […] ....

United States , Joshuat Brumm , Richard William Scalzo , Group Plc , Dyne Therapeutics Company Profile , Allspring Global Investments Holdings , Sphera Funds Management , Dyne Therapeutics Inc , Securities Exchange Commission , Tower Research Capital , Dyne Therapeutics , Free Report , Get Free Report , Exchange Commission , Global Investments Holdings , Funds Management , General Group Plc , Research Capital , Dyne Therapeutics Daily , Nyse Dyn , Stocknews Com ,

Dyne Therapeutics (NYSE:DYN) Stock Rating Lowered by StockNews.com

StockNews.com cut shares of Dyne Therapeutics (NYSE:DYN – Free Report) from a hold rating to a sell rating in a report issued on Saturday. Dyne Therapeutics Trading Down 0.2 % NYSE:DYN opened at $11.08 on Friday. The company’s 50 day moving average price is $12.22 and its 200-day moving average price is $11.89. Dyne Therapeutics […] ....

United States , Richard William Scalzo , Joshuat Brumm , Securities Exchange Commission , Sg Americas Securities , Deutsche Bank , Dyne Therapeutics Inc , Swiss National Bank , Principal Financial Group Inc , Dyne Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Exchange Commission , Financial Group , National Bank , Dyne Therapeutics Daily , Nyse Dyn , Stocknews Com ,